Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2004-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000099881.83261.D4PMID 14551155PMCID PMC2773540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Merlin—rapid analysis of dense genetic maps using sparse gene flow trees

  2002cited by this paper
• The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese.

  2002cited by this paper
• Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia.

  2002cited by this paper
• Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

  2002cited by this paper
• Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren

  2002cited by this paper
• Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

  2002cited by this paper
• Correcting for a potential bias in the pedigree disequilibrium test.

  2001cited by this paper
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

  2001cited by this paper
• Aberrant Signal Peptide Cleavage of Collagen X in Schmid Metaphyseal Chondrodysplasia

  2001influential reference
• New drug targets for type 2 diabetes and the metabolic syndrome

  2001cited by this paper
• Gamete-competition models.

  2000cited by this paper
• A test for linkage and association in general pedigrees: the pedigree disequilibrium test.

  2000cited by this paper
• Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.

  1999cited by this paper
• Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism.

  1999cited by this paper
• ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests.

  1999cited by this paper
• A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism.

  1999cited by this paper
• Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.

  1999cited by this paper
• A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

  1999cited by this paper
• Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.

  1998cited by this paper
• Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex.

  1998cited by this paper
• Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.

  1998cited by this paper
• A Mouse Model with Features of Familial Combined Hyperlipidemia

  1997cited by this paper
• SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites

  1997cited by this paper
• Phenotype expression in familial combined hyperlipidemia.

  1997cited by this paper
• Allele-sharing models: LOD scores and accurate linkage tests.

  1997cited by this paper
• Linkage analysis of complex traits using affected sibpairs: Effects of single‐locus approximations on estimates of the required sample size

  1997cited by this paper
• Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.

  1997cited by this paper
• Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

  1997cited by this paper
• Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.

  1996cited by this paper
• Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children

  1996influential reference
• Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites.

  1995cited by this paper
• Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia.

  1994cited by this paper
• Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.

  1993cited by this paper
• An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.

  1993cited by this paper
• Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.

  1992cited by this paper
• Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.

  1992influential reference
• An analysis of vertebrate mRNA sequences: intimations of translational control

  1991cited by this paper
• Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

  1991cited by this paper
• Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

  1990cited by this paper
• No Adjustments Are Needed for Multiple Comparisons

  1990cited by this paper
• Study of DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in patients with peripheral arterial disease.

  1989cited by this paper
• On measures of gametic disequilibrium.

  1988influential reference
• DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.

  1987cited by this paper
• Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association.

  1987cited by this paper
• Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.

  1973influential reference
• Family study of serum lipids and lipoproteins in coronary heart-disease.

  1973influential reference
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973influential reference
• Letter to the Editor Correcting for a Potential Bias in the Pedigree Disequilibrium Test

  year unknowncited by this paper

• Familial Combined Hyperlipidemia: Myth or Reality?

  2025cites this paper
• Research Progress on the Mechanism of Acute Hypertriglyceridemic Pancreatitis

  2024cites this paper
• Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome

  2023cites this paper
• Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?

  2022influential citation
• Apolipoprotein A5, a unique modulator of fasting and postprandial triglycerides.

  2022cites this paper
• Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks

  2022cites this paper
• Genetic variation in lean body mass, changes of appetite and weight loss in response to diet interventions: The POUNDS Lost trial

  2020cites this paper
• Management of hypertriglyceridemia

  2020cites this paper
• Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond

  2019cites this paper
• Interactions between Genetics and Sugar-Sweetened Beverage Consumption on Health Outcomes: A Review of Gene–Diet Interaction Studies

  2018cites this paper
• Quantitative trait loci at the 11q23.3 chromosomal region related to dyslipidemia in the population of Andhra Pradesh, India

  2017cites this paper
• Genetic determinants of clinical heterogeneity of the coronary artery disease in the population of Hyderabad, India

  2017cites this paper
• GLADIATOR: a global approach for elucidating disease modules

  2017cites this paper
• Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.

  2016cites this paper
• Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.

  2015cites this paper
• Genetics of coronary heart disease with reference to ApoAI-CIII-AIV gene region.

  2014cites this paper
• MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.

  2014cites this paper
• Influences of APOA5 Variants on Plasma Triglyceride Levels in Uyghur Population

  2014influential citation
• Apolipoprotein A5 gene variants and the risk of coronary heart disease: A case-control study and meta-analysis

  2013cites this paper
• CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients[S]

  2013cites this paper
• Chondrogenic differentiation of human umbilical cord blood‑derived mesenchymal stem cells by co‑culture with rabbit chondrocytes.

  2013cites this paper
• Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments.

  2012cites this paper
• Tamoxifen promotes superoxide production in platelets by activation of PI3-kinase and NADPH oxidase pathways.

  2012cites this paper
• The genetics of familial combined hyperlipidaemia

  2012cites this paper
• Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran lipid and glucose study

  2012cites this paper
• ASSOCIATION OF THE APOAI-CIII-AIV GENE CLUSTER POLYMORPHISMS WITH THE LEVEL OF LIPIDS IN TEHRANIAN POPULATION

  2012cites this paper
• Genetic and Functional Studies Provide Insights into the Aetiologies of Familial Combined Hyperlipidemia

  2012cites this paper
• Dyslipidemia in Patients with Lipodystrophy in the Use of Antiretroviral Therapy

  2012cites this paper
• Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels

  2011influential citation
• Stepwise Positive Association Between APOA5 Minor Allele Frequencies and Increasing Plasma Triglyceride Quartiles in Random Patients with Hypertriglyceridemia of Unclarified Origin

  2011cites this paper
• APOA4 Polymorphism as a Risk Factor for Unfavorable Lipid Serum Profile and Depression

  2011cites this paper
• Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

  2011cites this paper
• Association of PON1 and APOA5 Gene Polymorphisms in a Cohort of Indian Patients Having Coronary Artery Disease With and Without Type 2 Diabetes

  2011cites this paper
• Triglycerides and Cardiovascular Disease : A Scientific Statement From the

  2011cites this paper
• Hypertriglyceridaemia: Aetiology, Complications and Management

  2010cites this paper
• Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins

  2010cites this paper
• Genetics of metabolic syndrome and related traits

  2010cites this paper
• APOE/C1/C4/C2 Gene Cluster Genotypes, Haplotypes and Lipid Levels in Prospective Coronary Heart Disease Risk Among UK Healthy Men

  2010cites this paper
• Triglyceride level affecting shared susceptibility genes in metabolic syndrome and coronary artery disease.

  2010cites this paper
• FABP4 plasma levels are increased in familial combined hyperlipidemia

  2010cites this paper
• Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.

  2010cites this paper
• Putting the Invader assay to work: laboratory application and data management.

  2009cites this paper
• Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity

  2009cites this paper
• Gene-Gene Interaction between APOA5 and USF1: Two Candidate Genes for the Metabolic Syndrome

  2009cites this paper
• Hypertriglyceridemia: phenomics and genomics

  2009cites this paper
• FABP 4 plasma levels are increased in familial combined hyperlipidemia

  2009cites this paper
• Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.

  2009cites this paper
• New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia Supported by the Medical Research Council and the British Heart Foundation. Published, JLR Papers in Press, November 20, 2008.

  2009cites this paper
• Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study

  2009cites this paper
• Implication de l'apolipoprotéine AV dans le déterminisme des hyperchylomicronémies

  2009cites this paper
• Apoprotein A-V: An important regulator of triglyceride metabolism

  2008cites this paper
• Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.

  2008cites this paper
• Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A‐V deficiency due to a novel mutation in the APOA5 gene

  2008cites this paper
• Familial combined hyperlipidaemia: under - defined and under - diagnosed?

  2008cites this paper
• Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Gen de la apolipoproteína A5: asociación con el metabolismo de los triglicéridos y las enfermedades cardiovasculares

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• ApoA5: Ein wichtiger Regulator der Triglyzeride oder nur ein weiteres Apoprotein?

  2008cites this paper
• Molecular Background of Common Dyslipidemias

  2008cites this paper
• Artículo de revisión Aspectos genéticos de la hiperlipidemia familiar combinada

  2008cites this paper
• Aspectos genéticos de la hiperlipidemia familiar combinada

  2008cites this paper
• Génétique des hypertriglycéridémies

  2008cites this paper
• APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia

  2008cites this paper
• Genetic Analysis of Candidate Genes for the Metabolic Syndrome and Type 2 Diabetes

  2008cites this paper
• Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of genders⃞ Published, JLR Papers in Press, February 8, 2008.

  2008cites this paper
• Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of genders⃞

  2008cites this paper
• Frequent detection of familial hypercholesterolemia mutations in familial combined hyperlipidemia.

  2008cites this paper
• Military community: a privileged site for clinical research: Epidemiological Study of Metabolic Syndrome Risk Factors in the Military Environment.

  2008cites this paper
• Determinants of plasma apolipoprotein A‐V and APOA5 gene transcripts in humans

  2008cites this paper
• Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date

  2007cites this paper
• Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

  2007cites this paper
• Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice1 Published, JLR Papers in Press, April 16, 2007.

  2007cites this paper
• APOA5 variants and metabolic syndrome in Caucasianss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three tables, one figure. Published, JLR Papers in Press, September 3, 2007.

  2007cites this paper
• Apolipoprotein polymorphisms and familial hypercholesterolemia.

  2007cites this paper
• Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.

  2007cites this paper
• Genetic Epidemiology and Lipids: A Pattern So Grand and Complex

  2007influential citation
• Plasma apolipoprotein A5 and triglycerides in type 2 diabetes

  2006cites this paper
• Triglycerides and Risk for Atherosclerotic Disease

  2006cites this paper
• Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats

  2006cites this paper
• Unraveling the complex genetics of familial combined hyperlipidemia

  2006cites this paper
• Is apolipoprotein A5 a novel regulator of triglyceride‐rich lipoproteins?

  2006cites this paper
• APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.

  2006cites this paper
• Evidence for Consistent Intragenic and Intergenic Interactions between SNP Effects in the APOA1/C3/A4/A5 Gene Cluster

  2006cites this paper
• Genetics of familial combined hyperlipidemia

  2006cites this paper
• Contrasting multi‐site genotypic distributions among discordant quantitative phenotypes: the APOA1/C3/A4/A5 gene cluster and cardiovascular disease risk factors

  2006cites this paper
• A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration Published, JLR Papers in Press, June 16, 2005. DOI 10.1194/jlr.D500018-JLR200

  2005cites this paper
• Impact of Apolipoprotein A5 Polymorphisms on Insulin Sensitivity and β-cell Function

  2005cites this paper
• Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1

  2005cites this paper
• Genetics and molecular biology.

  2005cites this paper
• Determination of the Functionality of Common APOA5 Polymorphisms*

  2005cites this paper
• Give me A5 for lipoprotein hydrolysis

  2005cites this paper
• The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk

  2005cites this paper
• APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study Published, JLR Papers in Press, December 16, 2004. DOI 10.1194/jlr.M400437-JLR200

  2005cites this paper
• Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

  2005cites this paper
• Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population.

  2005cites this paper
• The Expression of Intact and Mutant Human apoAI/CIII/AIV/AV Gene Cluster in Transgenic Mice*

  2005cites this paper
• Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia

  2005influential citation
• Give me A5 for lipoprotein hydrolysis!

  2005cites this paper
• Searching for genes predisposing to common dyslipidemias

  2004cites this paper